Berry Wealth Group LP Cuts Holdings in CME Group Inc. $CME

Berry Wealth Group LP lessened its position in shares of CME Group Inc. (NASDAQ:CME) by 90.1% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,353 shares of the financial services provider’s stock after selling 12,369 shares during the period. CME Group comprises 1.2% of Berry Wealth Group LP’s investment portfolio, making the stock its 20th biggest holding. Berry Wealth Group LP’s holdings in CME Group were worth $366,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of CME. Caldwell Trust Co boosted its stake in CME Group by 116.3% in the third quarter. Caldwell Trust Co now owns 93 shares of the financial services provider’s stock valued at $25,000 after acquiring an additional 50 shares in the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA acquired a new stake in shares of CME Group during the third quarter worth about $27,000. Financial Consulate Inc. purchased a new stake in shares of CME Group in the 3rd quarter valued at about $28,000. Sagard Holdings Management Inc. acquired a new stake in shares of CME Group in the 2nd quarter valued at about $30,000. Finally, Corundum Trust Company INC purchased a new position in CME Group during the 3rd quarter worth approximately $30,000. 87.75% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at CME Group

In related news, Director Dennis Suskind sold 748 shares of the company’s stock in a transaction on Friday, February 6th. The shares were sold at an average price of $300.00, for a total transaction of $224,400.00. Following the completion of the sale, the director directly owned 2,699 shares of the company’s stock, valued at approximately $809,700. This represents a 21.70% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Martin J. Gepsman sold 300 shares of the stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $305.90, for a total value of $91,770.00. Following the completion of the sale, the director owned 24,999 shares of the company’s stock, valued at approximately $7,647,194.10. This trade represents a 1.19% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 30,248 shares of company stock worth $8,355,450. 0.30% of the stock is currently owned by company insiders.

CME Group Stock Down 1.0%

CME Group stock opened at $316.81 on Friday. CME Group Inc. has a fifty-two week low of $248.53 and a fifty-two week high of $329.16. The firm has a market capitalization of $114.24 billion, a price-to-earnings ratio of 28.39, a price-to-earnings-growth ratio of 3.72 and a beta of 0.24. The stock’s fifty day moving average is $291.37 and its two-hundred day moving average is $277.29. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.03 and a current ratio of 1.03.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.75 by $0.02. The firm had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.64 billion. CME Group had a return on equity of 14.65% and a net margin of 62.45%.CME Group’s revenue was up 8.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.52 EPS. Analysts predict that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 26th. Stockholders of record on Tuesday, March 10th will be issued a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.6%. The ex-dividend date is Tuesday, March 10th. This is a positive change from CME Group’s previous quarterly dividend of $1.25. CME Group’s payout ratio is currently 44.80%.

Analysts Set New Price Targets

CME has been the topic of a number of research reports. Morgan Stanley raised their target price on shares of CME Group from $319.00 to $340.00 and gave the stock an “overweight” rating in a research report on Thursday, February 5th. UBS Group reissued a “neutral” rating and set a $310.00 price objective on shares of CME Group in a research report on Friday, February 6th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of CME Group from $312.00 to $316.00 and gave the company a “buy” rating in a research note on Thursday, February 5th. The Goldman Sachs Group upped their target price on shares of CME Group from $264.00 to $266.00 and gave the company a “sell” rating in a report on Monday, February 9th. Finally, Piper Sandler raised their price target on CME Group from $296.00 to $313.00 and gave the stock an “overweight” rating in a report on Thursday, November 13th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have assigned a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $302.71.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Jefferies raised its price target on CME to $356, an analyst upgrade that supports a higher valuation and likely contributed to recent buying and the stock reaching a new 1‑year high. Analyst upward revisions can lend momentum and justify higher multiples for CME. Jefferies Boosts CME Price Target
• Positive Sentiment: CME also hit a new one‑year high following that analyst upgrade, signaling strong near‑term demand and positive sentiment among investors. That price peak may have increased visibility and trading in the shares. CME Hits New 1‑Year High
• Neutral Sentiment: Argus reiterated a “hold” rating on CME, a neutral endorsement that neither materially changes the sell‑side narrative nor provides a clear catalyst for price movement. Argus Hold Reaffirmed
• Neutral Sentiment: Crypto market commentary points to a potential Bitcoin move toward $80k and references an unfilled CME gap; if realized, stronger crypto prices could lift CME’s crypto‑futures volumes, but this outcome is uncertain and timing is unclear. Investors should view this as a possible upside to derivatives volumes rather than a guaranteed driver. Bitcoin Signals $80K Target
• Neutral Sentiment: Short‑interest data published for early March shows anomalous values (reported as 0 shares and NaN increases). The figures appear erroneous or incomplete, so they should not be treated as evidence of increased bearish positioning until corrected data is released. (No reliable source link available in the entry.)

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.